Clinical trial
Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological…
NCT00326807 · Centre for Addiction and Mental Health, Other · Completed
Key facts
| NCT number | NCT00326807 |
|---|---|
| Title | Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling |
| Lead sponsor | Centre for Addiction and Mental Health, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Concurrent Alcohol Dependence and Pathological Gambling |
| Intervention type | Drug |
| Interventions | Naltrexone |
| Enrollment | 50 |
| Start date | Jun 1, 2001 |
| Completion | Jun 1, 2004 |
| First posted | May 17, 2006 |
| Last update posted | May 17, 2006 |
| Countries | Canada, Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: